Commentary to "Carrimycin, a first in-class anti-cancer agent, targets selenoprotein H to induce nucleolar oxidative stress and inhibit ribosomal biogenesis"☆

Cancer Pathog Ther. 2023 Jan 24;1(2):157-158. doi: 10.1016/j.cpt.2023.01.005. eCollection 2023 Apr.

Author

Peng Lyu^{1

2}

Affiliations

¹ Cancer Pathogenisis and Therapy, Chinese Medical Association Publishing House, Beijing 100052, China.
² Key Laboratory of Knowledge Mining and Service for Medical Journals, National Press and Publication Administration, Beijing 100052, China.

No abstract available